Cancer Research Cancer Epigenetics Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masuda, M.
Right arrow Articles by Weinstein, I. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masuda, M.
Right arrow Articles by Weinstein, I. B.
[Cancer Research 62, 3351-3355, June 15, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Constitutive Activation of Signal Transducers and Activators of Transcription 3 Correlates with Cyclin D1 Overexpression and May Provide a Novel Prognostic Marker in Head and Neck Squamous Cell Carcinoma1

Muneyuki Masuda, Masumi Suzui, Ryuji Yasumatu, Torahiko Nakashima, Yuichiro Kuratomi, Kaoru Azuma, Kichinobu Tomita, Sohtaro Komiyama and I. Bernard Weinstein2

Herbert Irving Comprehensive Cancer Center, Columbia University, College of Physicians and Surgeons, HHSC-1509, New York, New York 10032 [M. M., M. S., I. B. W.]; Department of Othorhinolaryngology, Faculty of Medicine, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan [M. M., R. Y., T. N., Y. K., K. A., S. K.]; and Division of Head and Neck, National Kyushu Cancer Center, Minami-ku Fukuoka, 811-1395, Japan [K. T.]

The precise mechanism responsible for the frequent overexpression of cyclinD1 in human head and neck squamous cell carcinoma (HNSCC) is not known. In view of the fact that signal transducers and activators of transcription 3 (Stat3) is often activated in HNSCC cells, we examined the effects of Stat3 on cyclin D1 expression and cell proliferation in the YCU-H891 HNSCC cell line that displays constitutive activation of Stat3. Expression of a dominant negative Stat3 construct in YCU-H891 cells inhibited proliferation, cyclin D1 promoter activity, and cellular levels of cyclin D1 mRNA and protein. The levels of the antiapoptotic Bcl-2 and Bcl-XL proteins were also inhibited. In 51 primary tumor samples from patients with squamous cell carcinoma of the p.o. tongue, there was a significant correlation between increased levels of the activated form of Stat3, phosphorylated-Stat3, and increased levels of cyclin D1 (P < 0.0001). Increased tumor levels of phosphorylated-Stat3 were also associated with lower survival rates (P < 0.01). This study provides the first evidence that in HNSCC, constitutive activation of Stat3 plays a causative role in overexpression of cyclin D1, and in clinical studies, Stat3 activation may provide a novel prognostic factor. Furthermore, agents that target Stat3 may be useful in the treatment of HNSCC.




This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
C. Yang, J. H. Schwab, A. J. Schoenfeld, F. J. Hornicek, K. B. Wood, G. P. Nielsen, E. Choy, H. Mankin, and Z. Duan
A novel target for treatment of chordoma: signal transducers and activators of transcription 3
Mol. Cancer Ther., September 1, 2009; 8(9): 2597 - 2605.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Li, Y. Zang, M. Sen, R. J. Leeman-Neill, D. SK. Man, J. R. Grandis, and D. E. Johnson
Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death
Mol. Cancer Ther., August 1, 2009; 8(8): 2211 - 2220.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. B. Aggarwal, R.V. Vijayalekshmi, and B. Sung
Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
Clin. Cancer Res., January 15, 2009; 15(2): 425 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Abou-Ghazal, D. S. Yang, W. Qiao, C. Reina-Ortiz, J. Wei, L.-Y. Kong, G. N. Fuller, N. Hiraoka, W. Priebe, R. Sawaya, et al.
The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas
Clin. Cancer Res., December 15, 2008; 14(24): 8228 - 8235.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. R. Seethala, W. E. Gooding, P. N. Handler, B. Collins, Q. Zhang, J. M. Siegfried, and J. R. Grandis
Immunohistochemical Analysis of Phosphotyrosine Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor Autocrine Signaling Pathways in Head and Neck Cancers and Metastatic Lymph Nodes
Clin. Cancer Res., March 1, 2008; 14(5): 1303 - 1309.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Zhang, L. Gao, Y. Li, G. Lin, Y. Shao, K. Ji, H. Yu, J. Hu, D. V. Kalvakolanu, D. J. Kopecko, et al.
Effects of Plasmid-Based Stat3-Specific Short Hairpin RNA and GRIM-19 on PC-3M Tumor Cell Growth
Clin. Cancer Res., January 15, 2008; 14(2): 559 - 568.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
S. Choi and J.N. Myers
Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
Journal of Dental Research, January 1, 2008; 87(1): 14 - 32.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Zhang, L. Gao, L. Zhao, B. Guo, K. Ji, Y. Tian, J. Wang, H. Yu, J. Hu, D. V. Kalvakolanu, et al.
Intratumoral Delivery and Suppression of Prostate Tumor Growth by Attenuated Salmonella enterica serovar typhimurium Carrying Plasmid-Based Small Interfering RNAs
Cancer Res., June 15, 2007; 67(12): 5859 - 5864.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
V. W. Y. Lui, A. L. Boehm, P. Koppikar, R. J. Leeman, D. Johnson, M. Ogagan, E. Childs, M. Freilino, and J. R. Grandis
Antiproliferative Mechanisms of a Transcription Factor Decoy Targeting Signal Transducer and Activator of Transcription (STAT) 3: The Role of STAT1
Mol. Pharmacol., May 1, 2007; 71(5): 1435 - 1443.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Y. Feng, C. A. Lopez, D. P. Normolle, S. Varambally, X. Li, P. Y. Chun, M. A. Davis, T. S. Lawrence, and M. K. Nyati
Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy In vivo
Clin. Cancer Res., April 15, 2007; 13(8): 2512 - 2518.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Rong, L. Cheng, H. Ning, J. Zou, Y. Zhang, F. Xu, L. Liu, Z. Chang, and X.-Y. Fu
Wilms' Tumor 1 and Signal Transducers and Activators of Transcription 3 Synergistically Promote Cell Proliferation: A Possible Mechanism in Sporadic Wilms' Tumor
Cancer Res., August 15, 2006; 66(16): 8049 - 8057.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Yasui, H. Yamamoto, C. Y. Ngan, B. Damdinsuren, Y. Sugita, H. Fukunaga, J. Gu, M. Maeda, I. Takemasa, M. Ikeda, et al.
Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor-Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization
Clin. Cancer Res., August 1, 2006; 12(15): 4720 - 4729.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
T Akiyoshi, M Nakamura, K Koga, H Nakashima, T Yao, M Tsuneyoshi, M Tanaka, and M Katano
Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation
Gut, July 1, 2006; 55(7): 991 - 999.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
S.-L. Lu, H. Herrington, D. Reh, S. Weber, S. Bornstein, D. Wang, A. G. Li, C.-F. Tang, Y. Siddiqui, J. Nord, et al.
Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.
Genes & Dev., May 15, 2006; 20(10): 1331 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Leslie, C. Lang, G. Devgan, J. Azare, M. Berishaj, W. Gerald, Y. B. Kim, K. Paz, J. E. Darnell, C. Albanese, et al.
Cyclin d1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Cancer Res., March 1, 2006; 66(5): 2544 - 2552.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. L. Lee, J. Yeh, C. Van Waes, and Z. Chen
Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas
Mol. Cancer Ther., January 1, 2006; 5(1): 8 - 19.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. H. Dragnev, W. J. Petty, S. Shah, A. Biddle, N. B. Desai, V. Memoli, J. R. Rigas, and E. Dmitrovsky
Bexarotene and Erlotinib for Aerodigestive Tract Cancer
J. Clin. Oncol., December 1, 2005; 23(34): 8757 - 8764.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Gao, L. Zhang, J. Hu, F. Li, Y. Shao, D. Zhao, D. V. Kalvakolanu, D. J. Kopecko, X. Zhao, and D.-Q. Xu
Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo
Clin. Cancer Res., September 1, 2005; 11(17): 6333 - 6341.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. J. Petty, K. H. Dragnev, V. A. Memoli, Y. Ma, N. B. Desai, A. Biddle, T. H. Davis, W. C. Nugent, N. Memoli, M. Hamilton, et al.
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers
Clin. Cancer Res., November 15, 2004; 10(22): 7547 - 7554.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Aggarwal, Y. Takada, A. M. Mhashilkar, K. Sieger, S. Chada, and B. B. Aggarwal
Melanoma Differentiation-Associated Gene-7/IL-24 Gene Enhances NF-{kappa}B Activation and Suppresses Apoptosis Induced by TNF
J. Immunol., October 1, 2004; 173(7): 4368 - 4376.
[Abstract] [Full Text] [PDF]

Home page
 CROBMHome page
H. Siavash, N.G. Nikitakis, and J.J. Sauk
SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION: INSIGHTS INTO THE MOLECULAR BASIS OF ORAL CANCER
Critical Reviews in Oral Biology & Medicine, September 1, 2004; 15(5): 298 - 307.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J.-F. Jasmin, I. Mercier, R. Hnasko, M. W.-C Cheung, H. B Tanowitz, J. Dupuis, and M. P Lisanti
Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression
Cardiovasc Res, September 1, 2004; 63(4): 747 - 755.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
B. E. Barton, J. G. Karras, T. F. Murphy, A. Barton, and H. F-S. Huang
Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines
Mol. Cancer Ther., January 1, 2004; 3(1): 11 - 20.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
J. D. Khoury, L. J. Medeiros, G. Z. Rassidakis, M. A. Yared, P. Tsioli, V. Leventaki, A. Schmitt-Graeff, M. Herling, H. M. Amin, and R. Lai
Differential Expression and Clinical Significance of Tyrosine-phosphorylated STAT3 in ALK+ and ALK- Anaplastic Large Cell Lymphoma
Clin. Cancer Res., September 1, 2003; 9(10): 3692 - 3699.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
C. Melle, G. Ernst, B. Schimmel, A. Bleul, S. Koscielny, A. Wiesner, R. Bogumil, U. Moller, D. Osterloh, K.-J. Halbhuber, et al.
Biomarker Discovery and Identification in Laser Microdissected Head and Neck Squamous Cell Carcinoma with ProteinChip(R) Technology, Two-dimensional Gel Electrophoresis, Tandem Mass Spectrometry, and Immunohistochemistry
Mol. Cell. Proteomics, July 1, 2003; 2(7): 443 - 452.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. H. Hwang, D. W. Kim, J. M. Suh, H. Kim, J. H. Song, E. S. Hwang, K. C. Park, H. K. Chung, J. M. Kim, T.-H. Lee, et al.
Activation of Signal Transducer and Activator of Transcription 3 by Oncogenic RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinoma) Tyrosine Kinase: Roles in Specific Gene Regulation and Cellular Transformation
Mol. Endocrinol., June 1, 2003; 17(6): 1155 - 1166.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-W. Ni, H.-J. Hsieh, Y.-J. Chao, and D. L. Wang
Shear Flow Attenuates Serum-induced STAT3 Activation in Endothelial Cells
J. Biol. Chem., May 23, 2003; 278(22): 19702 - 19708.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Quintanilla-Martinez, M. Kremer, K. Specht, J. Calzada-Wack, M. Nathrath, R. Schaich, H. Hofler, and F. Fend
Analysis of Signal Transducer and Activator of Transcription 3 (Stat 3) Pathway in Multiple Myeloma: Stat 3 Activation and Cyclin D1 Dysregulation Are Mutually Exclusive Events
Am. J. Pathol., May 1, 2003; 162(5): 1449 - 1461.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. L. Leong, G. A. Andrews, D. E. Johnson, K. F. Dyer, S. Xi, J. C. Mai, P. D. Robbins, S. Gadiparthi, N. A. Burke, S. F. Watkins, et al.
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
PNAS, April 1, 2003; 100(7): 4138 - 4143.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.